The Global M&A Landscape: Q1 2026 in Review
Four months of mega-deals, AI land grabs, and a mining saga that won't quit
If you thought the M&A market was going to cool off after 2025’s late-cycle jitters, the first four months of 2026 would like a word. We tracked over 22,000 deals from January through April and the numbers tell a clear story: dealmakers are swinging big, conviction is back, and the sectors drawing capital have shifted dramatically.
This issue breaks down the four themes that defined the opening stretch of 2026, the headline deals you need to know, and the ones that got away.
1. The AI arms race goes full-throttle M&A
The biggest deal of the year (or decade?) landed in January when SpaceX absorbed xAI in an all-share transaction valuing the Elon Musk AI venture at $230 billion. Not bad for a company that barely existed two years ago. The deal consolidates Musk’s AI ambitions under the SpaceX umbrella and signals that the AI infrastructure race has entered its capital-intensive phase.
But xAI was just the headline. The AI M&A wave ran deep:
Google closed its $32B acquisition of Wiz in March, the largest cybersecurity deal ever, giving Alphabet a cloud-native security stack it badly needed.
Palo Alto Networks swallowed CyberArk for $25B in February, creating a cybersecurity platform spanning network security and identity management.
IBM acquired data streaming platform Confluent for $11B in March, betting that real-time data infrastructure is the connective tissue of enterprise AI.
In April, SpaceX was back — this time reportedly circling Anysphere (the company behind the Cursor AI coding assistant) at a $60B valuation. If completed, it would mark another Musk play to own the AI developer toolchain.
Even the rumour mill was AI-flavored: OpenAI was linked to Pinterest ($15.8B) — a play for visual training data — and Stripe reportedly explored absorbing PayPal ($40B), though PayPal quickly denied the talks.
The message is clear: the companies building the AI future aren’t waiting for organic growth. They’re buying it.
2. Pharma’s buying spree: the patent cliff has arrived
Big Pharma has been talking about the looming patent cliff for years. In early 2026, they stopped talking and started writing checks. The sector produced a remarkable density of $7B+ deals across all four months:
Abbott Laboratories acquired cancer diagnostics leader Exact Sciences for $23B in March — the largest diagnostics deal in history, positioning Abbott as the dominant player in early cancer detection.
Waters Corporation paid $18.8B for BD Biosciences in February, a bold move to build an end-to-end life sciences analytical platform.
Novartis bought RNA therapeutics pioneer Avidity Biosciences for $12B in February, doubling down on next-generation drug modalities.
Danaher launched a $9.9B cash bid for patient monitoring specialist Masimo at $180/share.
Gilead Sciences paid $7.8B for Arcellx in February, acquiring a next-gen CAR-T therapy pipeline to extend its cell therapy franchise.
Eli Lilly entered the in vivo cell therapy space with a $7B acquisition of Kelonia Therapeutics.
In April, India’s Sun Pharmaceutical made a $11.75B cross-border bid for Organon, targeting women’s health and biosimilars.
The thread connecting all of these? Platforms over products. Buyers are focused on acquiring technology platforms, diagnostic capabilities, and therapeutic modalities that can generate pipelines for a decade. It’s a structural shift in how pharma thinks about M&A.
3. European Banking is riding a consolidation wave
The banking sector delivered some of the period’s most consequential announced deals. This was most pronounced in Europe, where the long-awaited cross-border consolidation finally appears to be happening.
The marquee deal: UniCredit’s $39.3B bid for Commerzbank, announced in March. This is the deal European banking watchers have been waiting for. A cross-border merger that, if completed, would create a continental banking champion. The deal faces significant regulatory and political hurdles in Germany, but UniCredit’s persistence (after months of stake-building) suggests real commitment.
Meanwhile in the US and Asia…
Fifth Third Bancorp acquired Comerica for $10.9B in February, creating a top-10 US regional bank.
Huntington Bancshares bought Cadence Bank for $7.4B, extending its Southeast footprint.
In Asia, HSBC moved to take full control of Hang Seng Bank in a $13.6B deal in January, consolidating its Hong Kong franchise.
The pattern here is scale. With higher capital requirements, tighter margins, and the cost of technology modernization rising, mid-size banks are looking to scale.
4. Energy, Infrastructure and the “Mega-Deal Industrial Complex”
The physical world hasn’t gone away. If anything, the capital intensity of the energy transition and infrastructure buildout is producing deals that rival the tech sector in size.
Constellation Energy closed its $29.1B acquisition of Calpine in January — creating the largest clean energy producer in the US by generation capacity. With AI data centers driving unprecedented power demand, this deal looks prescient.
Deutsche Telekom reportedly explored acquiring the remaining 47% of T-Mobile US it doesn’t own for ~$101B in April. If it materializes, it would be among the largest telecom transactions ever.
Kone announced a €29.4B ($34.4B) acquisition of TKE in April, creating an elevator and escalator behemoth. The deal consolidates an industry that’s been circling itself for years.
A consortium of SMBC, Apollo, and Brookfield completed a $28.2B take-private of Air Lease Corporation in April, the largest aircraft leasing deal on record.
In France, a consortium of Bouygues, Iliad, and Orange announced a $24B restructuring of SFR, reshaping the French telecom market.
Other notable industrial deals: McCormick’s $20B cash acquisition of Unilever’s food business in March ($44.8B enterprise value including assumed debt), and Brad Jacobs’ QXO platform making a $17B play for building products distributor TopBuild in April.
What is means for the rest of 2026
Three takeaways
AI is the new strategic imperative. Every sector — tech, pharma, finance, industrials — is making AI-adjacent acquisitions. The deals aren’t just in “AI companies” anymore; they’re in the data, infrastructure, and platforms that make AI work.
Scale is in vogue. From banking to mining to telecom, the cost of technology, regulation, and competition is forcing consolidation across every industry that hasn’t already consolidated.
The rumor-to-deal pipeline is enormous. The volume of reported-then-denied deals (Stripe/PayPal, Nvidia/Dell, Musk/Ryanair) suggests that boards and advisors are running far more processes than are reaching the announcement stage. Many of these “denied” approaches will likely resurface — just as Rio/Glencore did.